TrialBMC pulmonary medicine2020

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa.

Sivagurunathan Sutharsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.